According to research at RNCOS, India is one of the most economical destinations for conducting global clinical trials. Their research shows that substantial amounts can be saved in India on both staff and utilities. For instance, the salary of a clinical research associate is only 13% of that in the US and 17% and 19% as that in the UK and Germany respectively. Similarly, the cost of a biostatistician in India is only 15%, 18% and 17% as that in the US, UK and Germany respectively. Companies also save substantially on utilities and land while setting up their operations in India. For more information on RNCOS research, please click here.
Will India prove to be the premier destination for global clinical trials in this economic climate? What does your company to do compete with the relatively low cost of companies utilizing India's resources? Post your thoughts here or on our LinkedIn group.
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
January
(20)
- Drug CROs: Good Medicine for Investors
- Quintiles partners with India’s Apollo Hospitals G...
- Kendle expands in India
- Free Webinar: The Benefits of Establishing a Gover...
- Read the January Partnerships with CROs LinkedIn R...
- Project Management in the Life Sciences: Results f...
- Indigo BioSystems Successfully Tests First Globall...
- Problems in Patient Recruitment in Outsourced Clin...
- ICON annouced as the Clinical Research Company of ...
- Icon increased 2008 earnings
- IRBs are Overloaded with Adverse Events
- South Africa seeing less funding for clinical trials
- FDA Limits Interest in Clinical Trials
- India Expected to Draw More Clinical Trials by 2012
- Insurance and clinical trials
- RNCOS: India Most Economical Destination for Globa...
- Merck and PPD Partner in Outsourcing Deal
- Brazil is critical base for PPD's CROs efforts
- India Offers More Education for Clinical Research
- Ethical Guidelines in India
-
▼
January
(20)
No comments:
Post a Comment